Table 3.
Gene | > 103 HSV gD transcriptsa |
< 5×102 HSV gD transcripts |
Day 20 |
---|---|---|---|
CCL2/MCP-1 | 8.80 | −8.65 | 1.55 |
CCL5/RANTES | 65.33 | 2.31 | 6.52* |
CCL7/MCP-3 | 5.67 | −1.44 | 1.40 |
CD4 | 5.22 | 1.10 | 2.66 |
CD8 alpha | 4.36 | −1.26 | 3.17 |
CD14 | 1.66 | −2.22 | 1.73 |
CD25 | 2.13 | −1.16 | 1.56 |
CD28 | 3.56 | −1.47 | 1.68 |
CD39 | −1.21 | −2.78 | 1.49 |
CD40 | 1.63 | 1.03 | 1.99 |
CD62L | −2.43* | −2.73 | −1.65 |
CD72 | 8.82 | −3.15 | 8.77 |
CD94 | 10.26 | 1.49 | 7.30 |
CD96 | 118.12 | 31.71 | 51.97 |
CD103 | −1.12 | 1.15 | 1.48 |
CD134 | −1.42 | −1.55 | −1.24 |
CD152/CTLA-4 | 49.12 | −17.78 | −1.13 |
CXCL10 | 107.59 | 30.39 | 6.91* |
CXCL11 | 354.47 | 21.16* | 17.89* |
CXCL12 | 2.54 | 1.27 | 1.67 |
IFNβ | −1.49 | −2.20 | −26.73 |
IFN γ | 134.01 | 4.14 | 12.49 |
IFNAR1 | −1.19 | −2.06 | 1.36 |
IFNAR2 | 1.62 | −1.50 | 1.39 |
IFNGR1 | 1.07 | −1.40 | 1.14 |
IL-1b | 1.85 | 1.71 | −1.02 |
IL-2 | 1.28 | −4.91 | 2.89 |
IL-4 | −1.24 | −1.81 | 1.14 |
IL-7 | 4.25 | 1.90 | 4.34* |
IL-10 | 2.81 | −7.14 | 1.62 |
IL-12 p35 | 1.01 | −5.13 | 1.22 |
IL-12 p40 | −1.41 | −10.06 | 1.49 |
IL-15 | 2.27 | −3.00 | 2.04 |
IL-17A | 1.02 | −1.07 | 1.14 |
IL-21 | 3.00 | −1.38 | 4.28 |
IL-27 | 1.87 | −1.19 | 1.88 |
IL-33 | 1.81 | 1.31 | 4.86* |
KLRG1 | −1.29 | −3.22 | 1.57 |
PRF-1 | 9.03 | −1.39 | 2.70 |
TGFβ | −1.08 | −2.52 | −1.12 |
TNFα | −1.40 | −1.74 | −1.53 |
Biopsies from lesion days 1 and 4 were segregated for analysis according to the number of HSV gD transcripts present (> 103 HSV gD (n=3) or < 5×102 HSV gD (n=4). Fold-change values marked with an asterisk reached statistical significance compared to gene expression in uninfected foreskin (p<0.05, Student’s t test).